Genetic and immunological dissection of isolated Nocardiosis

分离诺卡氏菌病的遗传和免疫学解剖

• 批准号: 10649575
• 负责人: Ruben Martinez Barricarte
• 金额: $ 25.95万
• 依托单位: VANDERBILT UNIVERSITY MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-06-17 至 2024-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10649575
• 关键词: Antibodies; Antibody Specificity; Antibody titer measurement; Antibody-mediated protection; Autoantibodies; Autoimmunity; Bacteria; Basic Science; Biological; Case Study; Cells; Chronic Granulomatous Disease; Clinical; Communicable Diseases; Computing Methodologies; Coupled; Cytometry; Data; Defect; Disease; Dissection; Epidemic; Exposure to; Family; Frequencies; Future; General Population; Genes; Genetic; Genetic Counseling; Gram-Positive Bacteria; Granulocyte-Macrophage Colony-Stimulating Factor; HIV Infections; Hereditary Disease; Human; Human Genetics; Iatrogenesis; Immune; Immune System Diseases; Immune response; Immunity; Immunologic Deficiency Syndromes; Immunologics; Immunology; Immunosuppression; Impairment; Individual; Infection; Inherited; Knowledge; Light; Malignant Neoplasms; Molecular; Molecular Biology; Molecular Diagnosis; Mutate; Mutation; Nocardia; Nocardia Infections; Outcome; Pathway interactions; Patients; Persons; Phagocytes; Phenotype; Physicians; Population Genetics; Predisposition; Prevalence; Preventive; Preventive therapy; Rare Diseases; Reactive Oxygen Species; Reporting; Risk; Risk Factors; Role; Severe Combined Immunodeficiency; System; T-Lymphocyte; Testing; Therapeutic; Traction; Translating; Work; acquired immunodeficiency; candidate identification; cell type; cofactor; cohort; computerized tools; congenital immunodeficiency; cytokine; disease-causing mutation; exome sequencing; fighting; genetic analysis; genetic architecture; genetic disorder diagnosis; hypogammaglobulinemia; impaired capacity; novel; pathogen; permissiveness; predictive tools; prevent; recruit; targeted treatment

PROJECT SUMMARY Nocardiosis is a severe infectious disease caused by the gram-positive bacteria Nocardia spp. Although exposure to the pathogen is universal, only a small fraction of exposed individuals develop severe disease. The observation that the epidemic (HIV infection) and iatrogenic (T cell immunosuppression) forms of nocardiosis are due to acquired immunodeficiency suggests that nocardiosis in otherwise healthy individuals may be due to inherited immunodeficiency. Further strengthening this point, patients with some primary immunodeficiencies (PIDs) such as chronic granulomatous disease (CGD)1–5, severe combined immunodeficiency (SCID)6, or hypogammaglobulinemia 7,8 develop nocardiosis. Hence, we hypothesize that nocardiosis in otherwise healthy individuals is an undiagnosed PID. We have recruited a growing cohort of patients without any detectable risk factors that develop severe nocardiosis to test this hypothesis. Furthermore, we have performed whole-exome sequencing (WES) in these patients and found that all the genes described to cause a PID are wild type suggesting that inborn errors of immunity in additional genes may account for nocardiosis in some of these patients. Interestingly, we have found that one-fifth of our patients carry neutralizing anti-GM-CSF auto- antibodies confirming that exposure to Nocardia spp. is necessary. Still, a permissive immune state of the host is required to develop the diseases. Therefore, this proposal aims to understand the genetic and immunological components of nocardiosis by using two complementary approaches. In our first specific aim, we will use a systems immunology approach to identify immunological abnormalities in the patients, such as the presence of auto-antibodies against cytokines, antibody deficiencies, or reduced frequencies of individual immune cells. We will gain valuable information regarding the pathways and cell types involved in anti-Nocardia immunity by performing these analyses. In our second specific aim, we will mine the WES data from the patients in search of new inborn errors of immunity. To this end, we will perform a genetic analysis combining population genetics, gene-level, and mutation-level predictive tools to identify mutations that can explain isolated nocardiosis. The work proposed in this application has far-reaching clinical and biological implications since it will seed light into the immune and genetic mechanisms critical to fending off Nocardia spp. Biologically, by studying patients with this rare disease, we will gain basic immunology knowledge of the vital and non-redundant roles of specific cell types, molecules, and pathways for the proper assembly of human immune responses. Clinically, this immunological knowledge could be translated into therapies for more common diseases, as has been the case by studying other PIDs9. Furthermore, our work will pave the way to provide genetic counseling and diagnosis to patients and families and propose preventive or targeted therapies for individuals at risk. Our proposal highlights the power of studying rare diseases for the basic and translational information that their study offers.

项目总结